Literature DB >> 8553307

Hypoxaemia and release of endothelin-1.

R I Cargill1, D G Kiely, R A Clark, B J Lipworth.   

Abstract

BACKGROUND: Secretion of the vasoconstrictor peptide endothelin-1 from vascular endothelium is increased by various stimuli. Whether hypoxaemia affects plasma levels of endothelin-1 in humans is unknown, but this may be important in the haemodynamic response to hypoxaemia. The plasma endothelin-1 concentrations in hypoxaemic humans has therefore been measured.
METHODS: Plasma levels of endothelin-1 were measured by specific radioimmunoassay in 10 control subjects at rest and following 30 minutes of acute hypoxaemia (SaO2 75-80%) induced by breathing a nitrogen/oxygen mixture, and in 10 patients with hypoxaemic cor pulmonale.
RESULTS: The plasma endothelin-1 concentration in control subjects was increased from a mean (SE) of 0.90 (0.11) pmol/l at baseline to 2.34 (0.34) pmol/l during hypoxaemia. In patients with cor pulmonale the plasma endothelin-1 concentration was 2.96 (0.34) pmol/l, raised in comparison with control subjects at rest but similar to levels in controls during hypoxaemia.
CONCLUSIONS: Plasma levels of endothelin-1 were increased by hypoxaemia in humans. The raised levels observed in patients with cor pulmonale may largely be attributable to the effects of hypoxaemia, although the pathophysiological significance of these observations remains to be established.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8553307      PMCID: PMC1021357          DOI: 10.1136/thx.50.12.1308

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  Cloning and expression of a cDNA encoding an endothelin receptor.

Authors:  H Arai; S Hori; I Aramori; H Ohkubo; S Nakanishi
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

2.  The endothelin family of peptides: local hormones with diverse roles in health and disease?

Authors:  W G Haynes; D J Webb
Journal:  Clin Sci (Lond)       Date:  1993-05       Impact factor: 6.124

3.  Effects of temperature on the phase behavior and permeability of thylakoid lipid vesicles : relevance to chilling stress.

Authors:  M S Webb; D V Lynch; B R Green
Journal:  Plant Physiol       Date:  1992-07       Impact factor: 8.340

4.  Endothelin-1 and cerebral blood flow: influence of hypoxia, hypercapnia and indomethacin on circulating endothelin levels in healthy volunteers.

Authors:  K Therkelsen; K A Jensen; M Freundlich; H Thorshauge; L Bünemann; L Bøgeskov Nielsen
Journal:  Scand J Clin Lab Invest       Date:  1994-10       Impact factor: 1.713

5.  Endothelin-1 in pulmonary hypertension associated with high-altitude exposure.

Authors:  S Goerre; M Wenk; P Bärtsch; T F Lüscher; F Niroomand; E Hohenhaus; O Oelz; W H Reinhart
Journal:  Circulation       Date:  1995-01-15       Impact factor: 29.690

6.  Discrimination between ETA- and ETB-receptor-mediated effects of endothelin-1 and [Ala1,3,11,15]endothelin-1 by BQ-123 in the anaesthetized rat.

Authors:  M Bigaud; J T Pelton
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

7.  Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat.

Authors:  S Oparil; S J Chen; Q C Meng; T S Elton; M Yano; Y F Chen
Journal:  Am J Physiol       Date:  1995-01

8.  Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 levels in conscious rats.

Authors:  G Shirakami; K Nakao; Y Saito; T Magaribuchi; M Jougasaki; M Mukoyama; H Arai; K Hosoda; S Suga; Y Ogawa
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

9.  Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

Authors:  D J Stewart; R D Levy; P Cernacek; D Langleben
Journal:  Ann Intern Med       Date:  1991-03-15       Impact factor: 25.391

10.  Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type.

Authors:  A P Davenport; G O'Reilly; R E Kuc
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

View more
  8 in total

1.  Cor Pulmonale.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-04

2.  Endothelin-1 as a novel target for the prevention of metabolic dysfunction with intermittent hypoxia in male participants.

Authors:  Jacqueline K Limberg; Sarah E Baker; Humphrey G Petersen-Jones; Winston Guo; An Huang; Michael D Jensen; Prachi Singh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-07-11       Impact factor: 3.210

3.  Endothelin-1 receptor blockade does not alter the sympathetic and hemodynamic response to acute intermittent hypoxia in men.

Authors:  Jacqueline K Limberg; Sarah E Baker; Elizabeth P Ott; Dain W Jacob; Zachariah M Scruggs; Jennifer L Harper; Camila M Manrique-Acevedo
Journal:  J Appl Physiol (1985)       Date:  2022-08-11

4.  Nitric oxide: an important role in the maintenance of systemic and pulmonary vascular tone in man.

Authors:  D G Kiely; A F Lee; A D Struthers; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

Review 5.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

6.  Endothelin-1 Serum Concentration in Pediatric Chronic Idiopathic Uveitis.

Authors:  Katarzyna Powierza; Jolanta Sawicka-Powierza; Beata Urban; Beata Żelazowska-Rutkowska; Bogdan Cylwik; Bożena Mikołuć; Olga Kowalewska; Alina Bakunowicz-Łazarczyk
Journal:  Clin Ophthalmol       Date:  2021-01-12

7.  Safety and Ergogenic Properties of Combined Aminophylline and Ambrisentan in Hypoxia.

Authors:  Thies Schroeder; Claude A Piantadosi; Michael J Natoli; Julie Autmizguine; Michael Cohen-Wolkowieczs; Karyn L Hamilton; Christopher Bell; Jelena Klawitter; Uwe Christians; David C Irwin; Robert J Noveck
Journal:  Clin Pharmacol Ther       Date:  2017-10-17       Impact factor: 6.875

8.  Effect of different high altitudes on vascular endothelial function in healthy people.

Authors:  Ning Fan; Cun Liu; Ming Ren
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.